Profit Or Loss [Abstract]

Pharming Group N.V. - Filing #5829944

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
297,200,000 USD
245,316,000 USD
Cost of sales
35,399,000 USD
25,212,000 USD
Gross profit
261,801,000 USD
220,104,000 USD
Other income
2,177,000 USD
23,349,000 USD
Administrative expenses
70,650,000 USD
55,877,000 USD
Other expense, by function
272,599,000 USD
248,840,000 USD
Profit (loss) from operating activities
8,621,000 USD
5,387,000 USD
Finance income
6,843,000 USD
3,663,000 USD
Finance costs
9,944,000 USD
9,069,000 USD
Profit (loss) before tax
8,492,000 USD
12,012,000 USD
Tax expense (income)
3,349,000 USD
1,464,000 USD
Profit (loss)
USD
11,841,000 USD
USD
USD
11,841,000 USD
USD
10,548,000 USD
10,548,000 USD
USD
USD
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.018
0.016
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.018
0.016

Talk to a Data Expert

Have a question? We'll get back to you promptly.